Allogeneic stem cells, clinical transplantation and the origins of regenerative medicine

Current Opinion in Immunology

Volumn 14, Issue 5, 2002, Pages 601-605

  Strom, Terry B ^a   Field, Loren J ^b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY   (United States)

^c Cardion AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; CELL DIFFERENTIATION; CELL LINE; EMBRYO CELL; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; MEDICAL ETHICS; REVIEW; SOMATIC CELL; STEM CELL TRANSPLANTATION;

EID: 0036775071     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(02)00387-4     Document Type: Review

References (18)

1. Amit M., Carpenter M.K., Inokuma M.S., Chiu C.P., Harris C.P., Waknitz M.A., Itskovitz-Eldor J., Thomson J.A. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol. 227:2000;271-278. To achieve consistency in producing a therapeutic dose of cells for transplantation, it may be very important to use clonally derived ES cells as a source for the cell transplants. This work shows that clonally derived ES cells maintain the pluripotency and proliferative potential needed for success.
2. Bjornson C.R., Rietze R.L., Reynolds B.A., Magli M.C., Vescovi A.L. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science. 283:1999;534-537.
3. Anderson D.J., Gage F.H., Weissman I.L. Can stem cells cross lineage boundaries? Nat Med. 7:2001;393-395. See annotation to [5••] .
4. Ying Q.L., Nichols J., Evans E.P., Amith A.G. Changing potency by spontaneous fusion. Nature. 416:2002;545-548. See annotation to [5••] .
5. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M et al.: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, published online 20 June 2002. DOI: 10.1038/nature00870.
6. Klug M.G., Soonpaa M.H., Koh G.Y., Field L.J. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest. 98:1996;216-224.
7. Reinlib L., Field L.J. Transplantation: future therapy for cardiovascular disease? An NHLBI Workshop. Circulation. 101:2000;e182-e187.
8. Minamino T., Yujiri T., Papst P.J., Chan E.D., Johnson G.L., Terada N. MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes. Proc Natl Acad Sci USA. 96:1999;15127-15132.
9. Li M., Pevny L., Lovell-Badge R., Smith A. Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr Biol. 8:1998;971-974.
10. Soria-Roche B., Berna E., Leon-Quinto G., Reig T., Martin J.A. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes. 40:2000;157-162.
11. Wells A.D., Li X.C., Li Y., Walsh M.C., Zheng X.X., Wu Z., Nunez G., Tang A., Sayegh M., Hancock W.W., et al. Requirement for T cell apoptosis in the induction of peripheral transplantation. Nat Med. 5:1999;1298-1302.
12. Li Y., Li X.C., Zheng X.X., Wells A.D., Turka L.A., Strom T.B. Blocking both signal 1 and signal 2 of T cell activation prevents apoptosis of cells and induction of peripheral allograft tolerance. Nat Med. 5:1999;1298-1302.
13. Li X.C., Strom T.B., Turka L.A., Wells A.D. T cell death and transplantation tolerance. Immunity. 14:2001;407-416.
14. Kim Y.S., Maslinski W., Zheng X.X., Stevens A.C., Li X.C., Tesch G.H., Kelley V.R., Strom T.B. Targeting the IL-15 receptor with an antagonist IL-15/Fc gamma2a protein blocks delayed type hypersensitivity. J Immunol. 160:1998;5742-5748.
15. Ferrari-Lacraz S., Zheng X.X., Kim Y.S., Li Y., Maslinski W., Li X.C., Strom T.B. An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection. J Immunol. 167:2001;3478-3485.
16. Chae D.W., Nosaka Y., Strom T.B., Maslinski W. The distribution of IL-15 receptor α chains on human PBMCs and the effect of immuno-suppressive drugs on receptor expression. J Immunol. 157:1996;2813-2819.
17. Marrack P., Bender J., Hildeman D., Jordan M., Mitchell T., Murakami I., Sakamoto A., Schaefer B.C., Swanson B., Kappler J. Homeostasis of alpha beta TCR+ T cells. Nat Immunol. 1:2000;107-111.
18. Li X.C., Demirci G., Ferrari-Lacraz S., Groves C., Coyle A., Malek T.R., Strom T.B. IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat Med. 7:2001;114-118.